| 5 min read
From an executive order to lower drug prices to GLP-1 drug comparisons and a link between Parkinson’s disease and golf courses, it was a busy industry news week.
| 3 min read
Backed by patient data and an AI platform, the BPGbio team presented promising results for a mitochondrial-targeted therapy in glioblastoma at AACR 2025.
| 8 min read
A new approach for gene editing will get its shot in a common and chronic autoimmune disorder.
| 4 min read
During mold infection, a cytokine sends signals to neutrophils to kill invading fungal spores in the lungs, enhancing survival.
| 4 min read
Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.News
| 4 min read
An executive order on drug manufacturing, a controversial HHS appointee, a diabetes drug for prostate cancers, and more were this week’s top industry headlines.
| 9 min read
Chemoproteomic tools are yielding early drug candidates for previously undruggable proteins.
| 5 min read
Among the thrill of new results presented at the AACR 2025 conference, the specter of funding cuts to cancer research hung over the meeting.
| 4 min read
The therapy lengthened telomeres and improved immune function in people with telomere biology disorder, showing promise for treating bone marrow failure safely.
| 3 min read
A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.
| 5 min read
Highlights from AACR 2025, COVID-19 vaccine flip flops, an FDA approval for a rare skin disorder, and more led biotech and pharma news this week.
Cancer Research News
Decoding the tumor microenvironment with immune profiling
Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.
Cepheid and Oxford Nanopore Technologies partner to advance automated sequencing-based solutions
Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases.
Editor's Pick
Explained: What is mesenchymal stem cell therapy?
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
Milestone: The history of bone marrow transplantation
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Bispecific antibody design handbook
With over 100 formats to choose from, designing bispecific antibodies demands both a clear understanding and the right tools to bring them to life.
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
